Ovarian germ cell tumors - a modern approach to the problem

Cover Page


Cite item

Full Text

Abstract

The article discusses epidemiology, the morphological, clinical features and modern principles of treatment of ovarian germ cell tumors (OGCT). New immunohistochemical markers are presented, and also the role of tumor markers is shown in the differential diagnosis of OGCT.

About the authors

Alina E Solopova

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: dr.solopova@mail.ru
Candidate of Medicine, assistant professor. Chair of radiology and radiotherapy, Faculty of Medicine

Yulia N Sologub

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: tigragnia@mail.ru
second-year resident. Chair of Obstetrics and Gynecology, Faculty of Preventive Medicine

Aleksandr D Makatsariya

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: gemostasis@mail.ru
Doctor of Medicine, Professor. Head of Chair of Obstetrics and Gynecology, Faculty of Preventive Medicine

Antonina G Solopova

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: antoninasolopova@yandex.ru
Doctor of Medicine, Professor. Chair of Obstetrics and Gynecology, Faculty of Preventive Medicine

References

  1. Hoffman BL, Schorge JO, Schaffer JI, Halvorson LM, et al. Williams Gynecology. 2nd ed. New York: McGraw-Hill; 2012.
  2. Berek JS, Hacker NF. Berek & Hacker’s gynecologic oncology. 6th ed. Philadelphia: Wolters Kluwer; 2015.
  3. Colombo N, Peiretti M, Garbi A, Carinelli S, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2012;23 (Suppl. 7):vii20-vii26. doi: 10.1093/annonc/mds223.
  4. Smith HO, Berwick M, Verschraegen CF, Wiggins C, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5): 1075-85. doi: 10.1097/01.AOG.0000216004.22588.ce.
  5. Mutter GL, Prat J. Pathology of the Female Reproductive Tract. 3rd edition. London: Churchill Livingstone Elsevier; 2014.
  6. Mosbech CH, Rechnitzer C, Brok JS, Meyts ER, et al. Recent Advances in Understanding the Etiology and Pathogenesis of Pediatric Germ Cell Tumors. J Pediatr Hematol Oncol. 2014;36:263-270. doi: 10.1097/MPH.0000000000000125.
  7. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol. 2005;97(2):519-23. doi: 10.1016/j.ygyno.2005.02.007.
  8. Horta M, Cunha TM; Lisbon/PT. Malignant Ovarian Germ Cell Tumours: Is there any clue for its diagnosis? 2014. doi: 10.1594/ecr2014/C-0485. Available at: http://dx.doi.org/10.1594/ecr2014/C-0485.
  9. Barakat RR, Berchuck A, Markman M, Randall ME. Principles and Practice of Gynecologic Oncology. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2013.
  10. Matei D, Brown J, Frazier L. Updates in the Management of Ovarian Germ Cell Tumors. 2013. Available at: http://meetinglibrary.asco.org/content/31-132.
  11. Breen J, Denehy T, et al. Pediatric Ovarian Malignancies. Glob Libr Women’s Med. 2008. doi: 10.3843/GLOWM.10251.
  12. Kurman RJ, Сarcanqiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs. Fourth Edition. IARS: Lyon; 2014. 307 p.
  13. Kurman RJ, Ellenson LH, Ronnett BM. Blausteins Pathology of the Female Genital Tract. 6th edition. New York: Springer Science+Business Media, LLC; 2011. doi: 10.1007/978-1-4419-0489-8.
  14. Мацко Д.Е., Иванцов А.О. Патологическая анатомия герминогенных опухолей // Практическаяонкология. - 2006. - Т. 7. - № 1. - С. 6-15. [Matsko DE, Ivantsov AO. Patologicheskaya anatomiya germinogennykh opukholei. Prakticheskaya onkologiya. 2006;7(1):6-15. (In Russ).]
  15. Peterson WF. Malignant degeneration of benign cystic teratomas of the ovary: a collective review of the literature. Obstet Gynecol Surv. 1957;12:793. doi: 10.1097/00006254-195712000-00001.
  16. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases. Cancer (Phila). 1976;37:2359. doi: 10.1002/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q.
  17. O’Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol. 1994;13:283. doi: 10.1097/00004347-199410000-00001.
  18. Nogales FF, Dulcey I, Preda O. Germ cell tumors of the ovary An update. Arch Pathol Lab Med. 2014;138:351-362. doi: 10.5858/arpa.2012-0547-RA. doi: 10.5858/arpa.2012-0547-RA.
  19. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013;62:71-88. doi: 10.1111/his.12052.
  20. Brown J, Friedlander M, Backes FJ, Harter P, et al. Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors. Int J Gynecol Cancer. 2014;24:S48-S54. doi: 10.1097/IGC.0000000000000223.
  21. Shaaban AM, Rezvani M, Elsayes KM, Baskin H, et al. Ovarian malignant germ cell tumors: cellular classification and clinical and imaging features. RadioGraphics. 2014;34:777-801. doi: 10.1148/rg.343130067.
  22. Kawata M, Sekiya S, Hatadeyama R, Takamizawa H. Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma. Gynecol Oncol. 1989;32:191-197. doi: 10.1016/S0090-8258(89)80032-0.
  23. Lawrence MR, Talerman A. Recent Advances in the Pathology and Classification of Ovarian Germ Cell Tumors. Int J Gynecol Pathol. 2006;25:305-320. doi: 10.1097/01.pgp.0000225844.59621.9d.
  24. Kaijser J, Bourne T, Valentin L, Sayasneh A, et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound Obstet Gynecol. 2013;41: 9-20. doi: 10.1002/uog.12323. doi: 10.1002/uog.12323.
  25. Alessandrino F, Dellafiore C, Eshja E, Alfano F, et al. Differential Diagnosis for Female Pelvic Masses. 2013. doi: 10.5772/53139.
  26. Бахтиозин Р.Ф., Сафиуллин Р.Р. Диффузионно-взвешенное исследование всего тела в диагностике и лечебном мониторинге злокачественных новообразований // Российский электронный журнал лучевой диагностики. - 2011. - Т. 1. - № 2. - С. 13-18. [Bakhtiozin R, Safiullin R. Whole-body diffusion-weighted imaging in diagnosis and monitoring of malignant neoplasm treatment. Russian Electronic Journal of Radiology. 2011;1(2):13-18. (In Russ).]
  27. Forstner R, Meissnitzer MW, Schlattau A, Spencer JA. MRI in ovarian cancer. Imaging Med. 2012;4(1):59-75. doi: 10.2217/iim.11.69.
  28. Lee SI, Catalano OA, Dehdashti F. Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging. J Nucl Med. 2015;56:436-443. doi: 10.2967/jnumed.114.145011.
  29. Mohaghegh P, Rockall AG. Imaging Strategy for Early Ovarian Cancer: Characterization of Adnexal Masses with Conventional and Advanced Imaging Techniques. RadioGraphics. 2012; 32:1751-1773. doi: 10.1148/rg.326125520.
  30. Zhang P, Cui Y, Li W, Ren G, et al. Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5T. World J of Surgical Oncology. 2012;10:237. Available at: http://www.wjso.com/content/10/1/237.
  31. Malek M, Pourashraf M, Mousavi AS, Rahmani M, et al. Differentiation of Benign from Malignant Adnexal Masses by Functional 3 Tesla MRI Techniques: Diffusion-Weighted Imaging and Time-Intensity Curves of Dynamic Contrast-Enhanced MRI. Asian Pac J Cancer Prev. 2015;16 (8):3407-3412. doi: 10.7314/APJCP.2015.16.8.3407.
  32. Prat J. FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1-5. doi: 10.1016/j.ijgo.2013.10.001.
  33. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Оvarian cancer including fallopian tube cancer and primary peritoneal cancer. Version 2.2015. Available at: http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf.
  34. Минимальные клинические рекомендации Европейского общества медицинской онкологии (ESMO) // Клинические рекомендации ESMO по диагностике, лечению и наблюдению при неэпителиальных опухолях яичников. - М., 2010. - С. 49-60. [Minimal’nye klinicheskie rekomendatsii evropeiskogo obshchestva meditsinskoi onkologii (ESMO). Klinicheskie rekomendatsii ESMO po diagnostike, lecheniyu i nablyudeniyu pri neepitelial’nykh opukholyakh yaichnikov. Moscow; 2010;49-60. (In Russ).]
  35. Давыдова И.Ю., Кузнецов В.В., Трякин А.А., Хохлова С.В. Клинические рекомендации по диагностике и лечению неэпителиальных опухолей яичников (проект). - М., 2014. - С. 5-15. [Davydova IY, Kuznetsov VV, Tryakin AA, Khokhlova SV. Klinicheskie rekomendatsii po diagnostike i lecheniyu neepitelial’nykh opukholei yaichnikov (proekt). Moscow; 2014;5-15. (In Russ).]
  36. Jewell EL. Germ Cell Tumor Treatment Protocols. Updated: Jan 21, 2015. Available at: http://emedicine.medscape.com/article/2156882-overview.
  37. Solheim O, Kaern J, Trope CG, et al. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009). Gynecol Oncol. 2013;131:330-335. doi: 10.1016/j.ygyno.2013.08.028.
  38. Union for International Cancer Control. Review of Cancer Medicines on the WHO List of Essential Medicines. Ovarian germ cell tumors. 2014. Available at: http://www.who.int/selection_medicines/committees/expert/20/applications/OvarianGermCell.pdf?ua=1.
  39. Тюляндин С.А. Герминогенные опухоли яичников // Практическая онкология. - 2006. - Т. 7. - № 1. - С. 52-61. [Tyulyandin SA. Germinogennye opukholi yaichnikov. Prakticheskaya onkologiya. 2006;7(1):52-61. (In Russ).]

Copyright (c) 2016 Solopova A.E., Sologub Y.N., Makatsariya A.D., Solopova A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies